Intelligence Platform
Patents
Browse 16 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11857697
Compositions and methods for obtaining 3-dimensional lung-like epithelium and related uses
granted patentUS 11441184
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem
granted patentUS 11261237
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating n
granted patentUS 10480031
Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem
granted patentUS 10081668
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating n
granted patentUS 9649340
Methods for producing enriched populations of human retinal pigment epithelium cells
granted patentUS 9339528
Methods for treating epithelium trauma of the intestinal mucosa using interleukin-1 recept
granted patentUS 8609408
Method for the reconstruction of a tissue-engineered human corneal endothelium
granted patentUS 7470659
Methods to increase reverse cholesterol transport in the retinal pigment epithelium (RPE)
granted patentUS 7179621
Pigment epithelium-derived factor: sequence of the PEDF gene
granted patentUS 6720180
Wounded epithelium-specific transcript
expired patentUS 6629970
Method of restoring endothelium of cornea
expired patentUS 6451763
Retinal pigmented epithelium derived neurotrophic factor and methods of use
expired patentUS 6319687
Pigment epithelium-derived factor: characterization, genomic organization and sequence of
expired patentUS 6153430
Nucleic acid encoding mesothelin, a differentiation antigen present on mesothelium, mesoth
expired patentUS 6083502
Mesothelium antigen and methods and kits for targeting it
expired